Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT07895407

Effects of Ciprofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime Surgery

Conditions: PND, POCD - Postoperative Cognitive Dysfunction

Sex: All
Ages: 65 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 148
Sponsor: Second Affiliated Hospital of Wenzhou Medical University

Location: Second Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang

Summary

As life expectancy increases, the rate of disability among elderly individuals is also rising. Elderly patients undergoing home-based rehabilitation after surgery without medical supervision may experience complications and adverse events such as nausea, vomiting, or bleeding, which can impair recovery of daily living functions and commonly lead to readmission after discharge-particularly in older adults with multiple comorbidities, declining physical function, or cognitive impairment, who face a higher risk. Postoperative neurocognitive disorder (PND) is common following anesthesia and surgery, affecting up to 65% of adults aged 65 and older, and is associated with significant morbidity and mortality. Most patients do not undergo baseline or follow-up neuropsychological testing during the perioperative period or afterward, limiting the identification and early intervention for PND. With increasing life expectancy and a growing number of elderly patients undergoing surgery, the incidence of PND is expected to continue rising, primarily manifesting as declines in memory, attention, information processing, and cognitive flexibility. Current clinical studies suggest that advanced age, low educational level, pre-existing cognitive impairment, and alcohol and/or substance abuse are strong risk factors for developing PND. The perioperative period represents a critical window for identifying and assessing PND.

Eligibility Criteria

Inclusion criteria: 1. Age ≥ 65 years 2. ASA I-II grade or ASA III grade, with stable coexisting diseases for more than 3 months, and after strict assessment and preparation for optimization. Exclusion criteria: 1. Acute central nervous system injury 2. Diseases with drug contraindications or severe lesions in important organs such as the heart, brain, lungs, etc. 3. Severe liver or kidney dysfunction 4. History of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis or other mental disorders in the past 5. History of alcoholism and/or drug abuse 6. Total intraoperative hypotension time ≥ 10 minutes or hypoxemia occurred 7. No responsible adult accompanying the patient 24 hours after discharge 8. Patients with poor language expression ability or unwillingness to follow the protocol or perform the procedures in this study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07895407). StuddyBuddy aggregates publicly available trial information.